SRPT logo

Sarepta Therapeutics (SRPT) Current assets

annual current assets:

$3.07B+$494.13M(+19.16%)
December 31, 2024

Summary

  • As of today (May 29, 2025), SRPT annual total current assets is $3.07 billion, with the most recent change of +$494.13 million (+19.16%) on December 31, 2024.
  • During the last 3 years, SRPT annual current assets has risen by +$469.36 million (+18.02%).
  • SRPT annual current assets is now at all-time high.

Performance

SRPT Current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTbalance sheet metrics

quarterly current assets:

$2.43B-$640.93M(-20.85%)
March 1, 2025

Summary

  • As of today (May 29, 2025), SRPT quarterly total current assets is $2.43 billion, with the most recent change of -$640.93 million (-20.85%) on March 1, 2025.
  • Over the past year, SRPT quarterly current assets has dropped by -$32.33 million (-1.31%).
  • SRPT quarterly current assets is now -20.85% below its all-time high of $3.07 billion, reached on December 31, 2024.

Performance

SRPT quarterly current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTbalance sheet metrics

Current assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

SRPT Current assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+19.2%-1.3%
3 y3 years+18.0%-3.9%
5 y5 years+109.2%-4.5%

SRPT Current assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+20.2%-20.9%at low
5 y5-yearat high+109.2%-20.9%+11.3%
alltimeall timeat high>+9999.0%-20.9%>+9999.0%

SRPT Current assets History

DateAnnualQuarterly
Mar 2025
-
$2.43B(-20.9%)
Dec 2024
$889.71M(+29.8%)
$3.07B(+14.5%)
Sep 2024
-
$2.69B(+0.1%)
Jun 2024
-
$2.68B(+8.9%)
Mar 2024
-
$2.46B(-4.4%)
Dec 2023
$685.25M(+20.1%)
$2.58B(+5.2%)
Sep 2023
-
$2.45B(-0.9%)
Jun 2023
-
$2.47B(-0.6%)
Mar 2023
-
$2.49B(-2.7%)
Dec 2022
$570.50M(+4.9%)
$2.56B(-2.6%)
Sep 2022
-
$2.63B(+6.3%)
Jun 2022
-
$2.47B(-2.4%)
Mar 2022
-
$2.53B(-2.8%)
Dec 2021
$543.88M(+8.9%)
$2.60B(+19.2%)
Sep 2021
-
$2.19B(-3.5%)
Jun 2021
-
$2.27B(-0.3%)
Mar 2021
-
$2.27B(-8.6%)
Dec 2020
$499.52M(+41.1%)
$2.49B(+7.0%)
Sep 2020
-
$2.32B(-5.6%)
Jun 2020
-
$2.46B(-3.5%)
Mar 2020
-
$2.55B(+73.4%)
Dec 2019
$353.91M(+63.9%)
$1.47B(+7.8%)
Sep 2019
-
$1.36B(-4.6%)
Jun 2019
-
$1.43B(-14.6%)
Mar 2019
-
$1.67B(+17.2%)
Dec 2018
$215.89M(+172.2%)
$1.43B(+40.9%)
Sep 2018
-
$1.01B(-11.2%)
Jun 2018
-
$1.14B(-6.6%)
Mar 2018
-
$1.22B(-0.8%)
Dec 2017
$79.32M(+56.7%)
$1.23B(+67.0%)
Sep 2017
-
$735.61M(+88.3%)
Jun 2017
-
$390.58M(-14.6%)
Mar 2017
-
$457.31M(+22.4%)
Dec 2016
$50.63M(+2.8%)
$373.48M(-14.1%)
Sep 2016
-
$434.74M(+183.8%)
Jun 2016
-
$153.19M(-4.7%)
Mar 2016
-
$160.73M(-28.4%)
Dec 2015
$49.24M(+4.2%)
$224.54M(+83.9%)
Sep 2015
-
$122.11M(-33.1%)
Jun 2015
-
$182.39M(-5.5%)
Mar 2015
-
$193.05M(-22.1%)
Dec 2014
$47.24M(+127.5%)
$247.80M(-8.2%)
Sep 2014
-
$269.81M(-11.4%)
Jun 2014
-
$304.67M(+22.2%)
Mar 2014
-
$249.37M(-7.9%)
Dec 2013
$20.76M(+87.3%)
$270.81M(-6.8%)
Sep 2013
-
$290.42M(+68.0%)
Jun 2013
-
$172.91M(-2.1%)
Mar 2013
-
$176.59M(-8.9%)
Dec 2012
$11.09M(+20.7%)
$193.91M(+359.9%)
Sep 2012
-
$42.16M(+26.9%)
Jun 2012
-
$33.23M(-11.7%)
Mar 2012
-
$37.63M(-16.7%)
Dec 2011
$9.18M(+12.9%)
$45.18M(-13.0%)
Sep 2011
-
$51.95M(-21.3%)
Jun 2011
-
$66.02M(+71.5%)
Mar 2011
-
$38.49M(+1.7%)
DateAnnualQuarterly
Dec 2010
$8.14M(-6.6%)
$37.84M(-10.6%)
Sep 2010
-
$42.31M(+6.0%)
Jun 2010
-
$39.93M(-9.6%)
Mar 2010
-
$44.15M(-14.0%)
Dec 2009
$8.72M(+2.6%)
$51.31M(-9.9%)
Sep 2009
-
$56.95M(+134.1%)
Jun 2009
-
$24.33M(-15.5%)
Mar 2009
-
$28.78M(+68.9%)
Dec 2008
$8.49M(-14.5%)
$17.04M(-13.3%)
Sep 2008
-
$19.66M(-12.8%)
Jun 2008
-
$22.55M(-11.1%)
Mar 2008
-
$25.36M(-11.7%)
Dec 2007
$9.93M(+43.4%)
$28.71M(+71.4%)
Sep 2007
-
$16.75M(-21.0%)
Jun 2007
-
$21.22M(-25.1%)
Mar 2007
-
$28.31M(-16.6%)
Dec 2006
$6.92M(-10.7%)
$33.94M(-13.6%)
Sep 2006
-
$39.29M(-12.9%)
Jun 2006
-
$45.10M(-11.2%)
Mar 2006
-
$50.77M(+4.3%)
Dec 2005
$7.75M(-6.8%)
$48.65M(+54.5%)
Sep 2005
-
$31.50M(-2.9%)
Jun 2005
-
$32.43M(-13.5%)
Mar 2005
-
$37.47M(+85.5%)
Dec 2004
$8.32M(-5.0%)
$20.20M(-15.1%)
Sep 2004
-
$23.80M(-19.7%)
Jun 2004
-
$29.65M(-20.2%)
Mar 2004
-
$37.16M(-3.2%)
Dec 2003
$8.75M(+6.7%)
$38.39M(+35.6%)
Sep 2003
-
$28.31M(-8.0%)
Jun 2003
-
$30.78M(+144.6%)
Mar 2003
-
$12.58M(-38.3%)
Dec 2002
$8.20M(+30.1%)
$20.40M(-11.4%)
Sep 2002
-
$23.03M(-23.9%)
Jun 2002
-
$30.27M(-20.6%)
Mar 2002
-
$38.10M(+38.5%)
Dec 2001
$6.30M(+222.1%)
$27.51M(-4.5%)
Sep 2001
-
$28.82M(-19.6%)
Jun 2001
-
$35.86M(+30.5%)
Mar 2001
-
$27.48M(-17.1%)
Dec 2000
$1.96M(+63.1%)
$33.13M(-13.4%)
Sep 2000
-
$38.27M(+261.1%)
Jun 2000
-
$10.60M(-26.6%)
Mar 2000
-
$14.43M(+23.3%)
Dec 1999
$1.20M(0.0%)
$11.70M(+368.0%)
Sep 1999
-
$2.50M(-43.2%)
Jun 1999
-
$4.40M(-34.3%)
Mar 1999
-
$6.70M(-25.6%)
Dec 1998
$1.20M(+9.1%)
$9.00M(-21.7%)
Sep 1998
-
$11.50M(-20.7%)
Jun 1998
-
$14.50M(-11.0%)
Mar 1998
-
$16.30M(-7.9%)
Dec 1997
$1.10M(-8.3%)
$17.70M(-4.3%)
Sep 1997
-
$18.50M(+5.1%)
Jun 1997
-
$17.60M(+665.2%)
Mar 1997
-
$2.30M
Dec 1996
$1.20M
-

FAQ

  • What is Sarepta Therapeutics annual total current assets?
  • What is the all time high annual current assets for Sarepta Therapeutics?
  • What is Sarepta Therapeutics annual current assets year-on-year change?
  • What is Sarepta Therapeutics quarterly total current assets?
  • What is the all time high quarterly current assets for Sarepta Therapeutics?
  • What is Sarepta Therapeutics quarterly current assets year-on-year change?

What is Sarepta Therapeutics annual total current assets?

The current annual current assets of SRPT is $3.07B

What is the all time high annual current assets for Sarepta Therapeutics?

Sarepta Therapeutics all-time high annual total current assets is $3.07B

What is Sarepta Therapeutics annual current assets year-on-year change?

Over the past year, SRPT annual total current assets has changed by +$494.13M (+19.16%)

What is Sarepta Therapeutics quarterly total current assets?

The current quarterly current assets of SRPT is $2.43B

What is the all time high quarterly current assets for Sarepta Therapeutics?

Sarepta Therapeutics all-time high quarterly total current assets is $3.07B

What is Sarepta Therapeutics quarterly current assets year-on-year change?

Over the past year, SRPT quarterly total current assets has changed by -$32.33M (-1.31%)
On this page